CG
Cognition, Depression, and Psychosocial Issues
Thursday, June 2, 2016: 6:15 PM-8:15 PM
Exhibit Hall
Case Series Examining Depressive Symptoms and Use of Behavioral Health Services in Bariatric Surgery Patients with Multiple Sclerosis
Carolyn J Fisher, Ph.D., Cleveland Clinic;
Leslie J. Heinberg, Ph.D., Cleveland Clinic;
Ali Aminian, M.D., Cleveland Clinic;
Stacy Brethauer, M.D., Cleveland Clinic;
Amy Sullivan, Psy.D., Cleveland Clinic
Preliminary Comparison of Baseline Cognition and Correlations with PROs of FTY Versus GA in MS Patients in a Longitudinal Observational Study
Brian D Hoyt, Ph.D., ABPP-CN, University of Colorado School of Medicine;
Justin Honce, MD, University of Colorado School of Medicine;
Stefan Silau, Ph.D., University of Colorado School of Medicine;
Brittany Wedeman, BS, University of Colorado School of Medicine;
Eric Engebretson, BA, University of Colorado School of Medicine;
Kristen Johnson, PhD, MPH, Novartis Pharmaceuticals Corporation;
Nadia Tenenbaum, MD, Novartis Pharmaceuticals Corporation;
Vivian Herrera, DDS, MIA, MPH, Novartis Pharmaceuticals Corporation;
Lisa Siconolfi, Ph.D., Novartis Pharmaceuticals Corporation;
Enrique Alvarez, MD, University of Colorado;
Kavita Nair, Ph.D., University of Colorado School of Pharmacy
Discrete Norms and Regression-Based Formulae for Interpreting the Minimal Assessment of Cognitive Function in Multiple Sclerosis: A Canadian Normative Study
David P Marino, M.S., University of Toledo;
Jason A Berard, M.A., The Ottawa Hosptial Research Institute;
Denis Cousineau, Ph.D., University of Ottawa;
Anthony Feinstein, PhD, MD, University of Toronto;
Sarah A Morrow, MD, Western University;
Lisa A.S. Walker, Ph.D., The Ottawa Hosptial Research Institute
Differences in Pain, Pain-Related Physical and Emotional Functioning and MS-Related Impairment By the Number of Pain Locations in MS
Elizabeth S Gromisch, Ph.D., Yale University School of Medicine;
Robert D Kerns, Ph.D., VA Connecticut Healthcare System;
Rebecca Czlapinski, M.A., VA Connecticut Healthcare System;
Beth Beenken, Ph.D., Yale University School of Medicine;
John Otis, Ph.D., Boston University;
John Beauvais, Ph.D., VA Connecticut Healthcare System
Development and Validation of the MS Resiliency Scale
Elizabeth S Gromisch, Ph.D., Yale University School of Medicine;
Jessica H Sloan, BA, Yeshiva University;
Vance Zemon, Ph.D., Yeshiva University;
Tuula Tyry, PhD, Dignity Health, St. Joseph's Hospital and Medical Center;
Laura C Schairer, Ph.D., VA NY Harbor Healthcare System;
Stacey Snyder, Ph.D., Mount Sinai Hospital;
Frederick W Foley, Ph.D., Holy Name Medical Center
The Effects of Reward and Incentive on Performance on the Symbol Digit Modalities Test (SDMT) in MS
Gabriel Hoffnung, MA, Yeshiva University;
Nicholas A Vissicchio, B.A., Yeshiva University Ferkauf Graduate School of Psychology;
Jeffrey G Portnoy, B.A., Yeshiva University;
Caroline Altaras, B.A., Yeshiva University Ferkauf Graduate School of Psychology;
Lisa Glukhovsky, M.A., Yeshiva University;
Mary Ann Picone, M.D., Holy Name Medical Center;
Frederick W Foley, Ph.D., School of Psychology, Yeshiva University
The Effects of Learning on Cognitive Fatigue in MS
Gabriel Hoffnung, MA, Yeshiva University;
Nicholas A Vissicchio, B.A., Yeshiva University Ferkauf Graduate School of Psychology;
Jeffrey G Portnoy, B.A., Yeshiva University;
Eliana Pasternak, B.A., Yeshiva University;
Lisa Glukhovsky, M.A., Yeshiva University;
Mary Ann Picone, M.D., Holy Name Medical Center;
Frederick W Foley, Ph.D., School of Psychology, Yeshiva University
Stability of Depression in Patients with Multiple Sclerosis
Jason Botvinick, B.A., Yeshiva University;
Jeffrey G Portnoy, B.A., Yeshiva University;
Gabriel Hoffnung, MA, Yeshiva University;
Lisa Glukhovsky, M.A., Yeshiva University;
Frederick W Foley, Ph.D., School of Psychology, Yeshiva University
Disability Predicts Longitudinal Depression in People with Multiple Sclerosis
Jason Botvinick, B.A., Yeshiva University;
Jeffrey G Portnoy, B.A., Yeshiva University;
Gabriel Hoffnung, MA, Yeshiva University;
Lisa Glukhovsky, M.A., Yeshiva University;
Frederick W Foley, Ph.D., School of Psychology, Yeshiva University
Longitudinal Efficacy of Antidepressant Pharmacotherapy in Multiple Sclerosis
Jeffrey G Portnoy, B.A., Yeshiva University;
Jason Botvinick, B.A., Yeshiva University;
Gabriel Hoffnung, MA, Yeshiva University;
Lisa Glukhovsky, M.A., Yeshiva University;
Frederick W Foley, Ph.D., Holy Name Medical Center
The Feasibility of a Positive Psychology Group Intervention for Patients with Multiple Sclerosis
Kaitlynne Leclaire, BA, Brigham and Women's Hospital;
Bonnie I Glanz, PhD, Brigham and Women's Hospital;
Allison LaRussa, BA, Brigham and Women's Hospital;
Fiona Stuart, BA, Brigham and Women's Hospital;
Brian C Healy, PhD, Brigham and Women's Hospital;
Jeff Huffman, MD, Massachusetts General Hospital;
Tanuja Chitnis, MD, Massachusetts General Hospital for Children;
Howard L Weiner, MD, Brigham and Women's Hospital;
Audrey H Cecil, MSW, LICSW, Brigham & Women's Hospital
Motor and Cognitive Predictors of Fall Risk in Multiple Sclerosis
Lisa Glukhovsky, M.A., Yeshiva University;
Gabriel Hoffnung, MA, Yeshiva University;
Jason Botvinick, B.A., Yeshiva University;
Jeffrey G Portnoy, B.A., Yeshiva University;
Marnina B Stimmel, B.A., Yeshiva University;
Roee Holtzer, PhD, Yeshiva University;
Frederick W Foley, Ph.D., School of Psychology, Yeshiva University
TeriMOOD Study Design: Assessing Changes in Depressed Mood in Patients with RMS Switching from IFNB to Teriflunomide Due to Symptoms of Depression
Lori Hendin Travis, MD, Phoenix Neurological Associates Ltd;
Jeffrey Chavin, MD, Genzyme, a Sanofi company;
Maria Melanson, MD, PhD, Genzyme, a Sanofi company;
Adel Gehchan, MD, Genzyme Canada;
Matt Mandel, MD, Genzyme, a Sanofi company
Longitudinal Evaluation of Cognition in Multiple Sclerosis: Impact of Cognitive Reserve
Louise M Gresham, B.Sc.H., University of Ottawa;
Roxana M Barbu, M.Cog., Carleton University;
Jason A Berard, B.Sc.H., University of Ottawa;
Lisa A.S. Walker, PhD, C.Psych., The Ottawa Hospital;
Louise M Gresham, B.Sc.H., University of Ottawa
Validity and Reliability of the Auditory Consonant Trigrams Test in Multiple Sclerosis
Maha Abu-AlHawa, B.Sc.H., Carleton University;
Jason A Berard, B.Sc.H., University of Ottawa;
Leila Osman, BA., Ottawa Hospital Research Institute;
Louise M Gresham, B.Sc.H., University of Ottawa;
Lisa A.S. Walker, PhD, C.Psych., The Ottawa Hospital
Effects of Fingolimod on Cognitive Status in Patients with Multiple Sclerosis: Prospective, Controlled Trial
Serkan Ozakbas, Professor Of Neurology, Dokuz Eylul University;
Bilge Piri Cinar, MD, Giresun State Hospital;
Gorkem Kosehasanogullari, MD, Usak State Hospital;
Pinar Yigit, Psycologist, Dokuz Eylul University;
Serkan Ozakbas, Professor Of Neurology, Dokuz Eylul University
Examining the Role of Mindfulness and Emotion Regulation Strategy Use in Emotion Dysregulation in Multiple Sclerosis
Thomas R Valentine, BS, The Ohio State University;
Brittney Schirda, MA, The Ohio State University;
Jacqueline A Nicholas, MD, MPH, OhioHealth Multiple Sclerosis Center;
Ruchika Prakash, PhD, The Ohio State University;
Ruchika Prakash, PhD, The Ohio State University;
Thomas R Valentine, BS, The Ohio State University
